CDC and FDA Declares Joint Statement in Johnson & Johnson COVID vaccine

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are giving a second thought and declaring a pause on the Johnson & Johnson COVID vaccine this April 2021 for the safety of the people.

COVID19 vaccine is given top priority these days. People worldwide are trying all kinds of immune boosters to help them stay away from viruses. Pharma companies are giving in their best to come out with efficient vaccines and medicines that can help the general public. The governments of all countries worldwide are executing various plans that can help stop the spread of coronavirus.  Right from imposing restrictions to lockdown, the government has put in a lot of effort to curb coronavirus spread.

The authorization of the COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have gone ahead and given the green flag to COVID  vaccines for use by the general public worldwide. They have approved COVID vaccines under the Emergency Authorization Use for the betterment of the people. The  Food and Drug Administration (FDA) is working to address the concerns about vaccines among people, to protect and promote the health of the entire population. They are focussing on the strategies that address health disparity.

Side effects of the COVID vaccine are a major concern 

The use of the coronavirus vaccine has brought about a major concern of side effects in immunized people. The major fear of blood clots has been rising among the people about the coronavirus vaccine. This has been noticed in people receiving the Johnson & Johnson (J&J) vaccine which has been administered. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are reviewing data of the six cases reported by the USA  where cases of rare and severe blood clots in the individual have been seen after receiving the  Johnson & Johnson (J&J) vaccine. A type of blood clot called Cerebral Venous Sinus Thrombosis(CVST) was seen in a combination of low platelet count, Thrombocytopenia. 

Details of the six cases detected an under review by The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)

All six cases which are under review were seen in the age group between 18 - 48. The symptoms of the blood clot called Cerebral Venous Sinus Thrombosis(CVST) and Thrombocytopenia occurred between 6 - 13 days after vaccination. Administering the COVID vaccine is led to this side effect of blood clots which needs immediate medical attention by The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The general conventional treatment of administering the anticoagulant called heparin is used to treat blood clots may be dangerous. We need to make sure that the vaccine has no interactions with the conventional treatment that is used by the patients. 

FDA ensures efficacy and safety of COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)  will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) to further review these six cases of blood clot side effects with COVID vaccine that has come into light this April 2021. FDA will review the analysis and also instigate the cases. Until the process is complete and under review, The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are recommending a pause to the use of the vaccine which is the need of the hour. This is a very important announcement by the FDA to ensure that healthcare professionals are aware of the side effects of this vaccine.

Tags : #medicircle #myhealth #FDA #CDC #COVIDvaccine #COVIDvaccinesideeffects

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024